Table 2. Patient Characteristics Associated With Statin Use Within 30 Days of Discharge.
| Characteristic | % Used statin | Adjusted OR (95% CI)a | P value |
|---|---|---|---|
| Age, y | |||
| <65 | 55.3 | 1 [Reference] | NA |
| 65-74 | 60.9 | 1.26 (1.24-1.28) | <.001 |
| ≥75 | 52.1 | 0.95 (0.94-0.97) | <.001 |
| Sex | |||
| Male | 61.7 | 1 [Reference] | NA |
| Female | 49.7 | 0.81 (0.80-0.82) | <.001 |
| Race | |||
| Asian | 54.8 | 1.07 (1.03-1.12) | .002 |
| Black | 52.5 | 0.90 (0.88-0.93) | <.001 |
| Hispanic | 50.5 | 0.90 (0.88-0.92) | <.001 |
| White | 57.7 | 1 [Reference] | NA |
| Other/unknown | 56.9 | 0.98 (0.94-1.03) | .39 |
| ASCVD type | |||
| MI, angina, or revascularization | 79.2 | 1 [Reference] | NA |
| Ischemic stroke or TIA | 55.5 | 0.34 (0.33-0.35) | <.001 |
| PAD | 35.4 | 0.14 (0.14-0.15) | <.001 |
| Hypertension | |||
| No | 42.0 | 1 [Reference] | NA |
| Yes | 59.2 | 1.77 (1.74-1.81) | <.001 |
| Diabetes | |||
| No | 52.9 | 1 [Reference] | NA |
| Yes | 62.1 | 1.47 (1.45-1.50) | <.001 |
| Stage 3-5 CKD | |||
| No | 55.7 | 1 [Reference] | NA |
| Yes | 59.9 | 1.04 (1.01-1.06) | .006 |
| Heart failure | |||
| No | 55.0 | 1 [Reference] | NA |
| Yes | 62.3 | 0.84 (0.82-0.86) | <.001 |
| Index year | |||
| 2007 | 50.3 | 1 [Reference] | NA |
| 2008 | 51.2 | 1.04 (1.01-1.08) | .02 |
| 2009 | 53.6 | 1.17 (1.13-1.21) | <.001 |
| 2010 | 55.0 | 1.25 (1.21-1.29) | <.001 |
| 2011 | 56.7 | 1.36 (1.31-1.41) | <.001 |
| 2012 | 57.0 | 1.38 (1.34-1.43) | <.001 |
| 2013 | 58.7 | 1.51 (1.46-1.56) | <.001 |
| 2014 | 59.1 | 1.54 (1.49-1.60) | <.001 |
| 2015 | 59.8 | 1.59 (1.54-1.64) | <.001 |
| 2016 | 59.9 | 1.60 (1.55-1.66) | <.001 |
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CKD, chronic kidney disease; NA, not applicable; OR, odds ratio; PAD, peripheral artery disease; TIA, transient ischemic attack.
a
Adjusted odds ratios were obtained from a multivariable logistic regression with statin use as the outcome variable and all these baseline characteristics as independent variables.